Profil bibliographique

X. Deprez

Informations fournies par OpenAlex. Research Africa ne déduit ni nationalité, ni poste, ni coordonnées personnelles.

59Publications signalées
653Citations signalées
0Affiliations récentes

Les domaines associés

Rheumatoid Arthritis Research and TherapiesSpondyloarthritis Studies and TreatmentsInfectious Diseases and TuberculosisSystemic Lupus Erythematosus ResearchPsoriasis: Treatment and Pathogenesis

Les publications récentes

2024 article OpenAlex

Do SMS/e-mail reminders increase influenza vaccination of rheumatoid arthritis patients under anti-TNF: a nested randomized controlled trial in the ART e-cohort

Yann Nguyen, Gabriel Baron, Naima Hamamouche, Rakiba Belkhir et autres

OBJECTIVES: The objectives of this study were to evaluate the effectiveness of short message service (SMS) and/or email reminders in improving influenza vaccination coverage rates among RA patients treated with anti-TNF therapies, and to identify factors associated with vaccination. METHODS: This study …

fr, ca, mc (code pays fourni par la source)

2 citations Lara D. Veeken
Accès ouvert 2023 article OpenAlex

Usefulness of 18F-Fluorodeoxyglucose Positron Emission Tomography in Diagnosing Polymyalgia Rheumatica and Large-Vessel Vasculitis: A Case-Control Study

Anne Desvages, Florent Hives, X. Deprez, Adeline Piérache et autres

Introduction: We aimed to evaluate the utility of FDG-PET/CT in diagnosing polymyalgia rheumatica (PMR) and associated large-vessel vasculitis (LVV). Methods: We analyzed FDG-PET/CT completed between 2015 and 2019 on patients diagnosed with PMR. For comparisons, patients with PMR were matched 1:1 to …

fr (code pays fourni par la source)

6 citations Journal of Clinical Medicine
Accès ouvert 2022 article OpenAlex

Characteristics of Patients Treated with JAK Inhibitors in Rheumatoid Arthritis before versus after VTE Risk Warnings

Cécile Philippoteaux, Valentine Deprez, Aurore Nottez, Émeline Cailliau et autres

Background: Baricitinib (BARI) or Tofacitinib (TOFA) were the first Janus Kinase Inhibitors (JAKi) to be marketed in rheumatoid arthritis (RA). Concerns regarding venous thromboembolism (VTE) risk have emerged during the past years. The aim of the study was to compare the baseline …

fr (code pays fourni par la source)

17 citations Journal of Clinical Medicine
Accès ouvert 2020 article OpenAlex

Secukinumab and ustekinumab treatment in psoriatic arthritis: results of a direct comparison

Jean-Guillaume Letarouilly, B. Flachaire, Céline Labadie, Maéva Kyheng et autres

OBJECTIVES: To evaluate the characteristics of patients (pts) with PsA treated by ustekinumab (UST) or secukinumab (SEK) and to compare real-world persistence of UST and SEK in PsA. METHODS: In this retrospective, national, multicentre cohort study, pts with PsA (CASPAR criteria or …

fr (code pays fourni par la source)

16 citations Lara D. Veeken
Notice OpenAlex

BNTIC News n’est pas le producteur de ces données. Les publications sont interrogées à la demande dans Crossref, OpenAIRE, DOAJ, Europe PMC, HAL, DataCite, AfricArXiv, ROR et la Banque mondiale, sans clé d’accès. OpenAlex reste optionnel. Aucun service payant n’est nécessaire et aucune donnée externe n’est enregistrée en base. Consulter les sources et leurs limites.